ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 178 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,683,000 | -53.8% | 40,469 | -46.6% | 0.17% | -56.7% |
| Q4 2020 | $5,812,000 | +75.1% | 75,752 | -1.8% | 0.40% | +71.1% |
| Q3 2020 | $3,320,000 | +1.7% | 77,108 | +1.9% | 0.23% | +1.8% |
| Q2 2020 | $3,266,000 | +47.6% | 75,635 | -1.7% | 0.23% | +36.5% |
| Q1 2020 | $2,213,000 | -47.1% | 76,924 | +16.7% | 0.17% | -32.7% |
| Q4 2019 | $4,181,000 | +9.3% | 65,926 | -51.4% | 0.25% | +4.6% |
| Q3 2019 | $3,824,000 | +1.0% | 135,699 | -5.0% | 0.24% | -1.2% |
| Q2 2019 | $3,786,000 | -45.1% | 142,887 | -62.0% | 0.24% | -45.1% |
| Q1 2019 | $6,895,000 | +25.2% | 375,754 | -15.3% | 0.44% | +15.3% |
| Q4 2018 | $5,506,000 | -37.6% | 443,375 | -3.7% | 0.38% | -26.3% |
| Q3 2018 | $8,826,000 | -14.3% | 460,423 | -39.2% | 0.51% | +2.0% |
| Q2 2018 | $10,297,000 | +97.2% | 757,137 | +4.5% | 0.50% | +105.7% |
| Q1 2018 | $5,221,000 | +98.8% | 724,228 | +1.5% | 0.24% | +129.0% |
| Q4 2017 | $2,626,000 | – | 713,722 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |